Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.

CONCLUSION: lupus anticoagulant diagnosis in rivaroxaban and apixaban samples drawn at trough levels remains questionable whenever positive results are obtained. If LA testing in apixaban samples might be useful to rule-out LA using dRVVT and/or aPTT-based assays, the wide majority of rivaroxaban samples would give false positive results. PMID: 31487115 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31487115?dopt=Abstract

Source: International Journal of Laboratory Hematology - September 4, 2019 Category: Hematology Authors: Gay J, Duchemin J, Imarazene M, Fontenay M, Jourdi G Tags: Int J Lab Hematol Source Type: research

More News: Hematology | Laboratory Medicine | Lupus | Study